ABIVAX (ABVX) revenue

There is no revenue history on record here for ABIVAX (ABVX). Figures as of 18 Nov 2026, 09:57 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; none is on record here for ABIVAX. Nothing is estimated to fill the gap.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of ABIVAX and comparable companies
CompanyRevenueFiscal year
Alkermes ALKS$1.48B2025
PACS Group PACS$5.29B2025
Kiniksa Pharmaceuticals International KNSA$677.56M2025
ImmunityBio IBRX$113.29M2025
Cytokinetics CYTK$88.04M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABVX

ABIVAX, figure by figure

ABIVAX (ABVX) overview: price, valuation and scorecardAll health care companies by market value

ABIVAX revenue: questions and answers

How is ABIVAX's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ABIVAX (ABVX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ABVX/revenue

Underlying data: Yahoo Finance.